SCHEMBL22235509

SCHEMBL22235509

COc1cc2c(c3cccnc13)C[C@H](C(C)(C)C)c1cc(C(=O)O)c(=O)[nH]c1-2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.34
▸ DHODH Q02127 2/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ FABP5 Q01469 1/20 0.32
▸ CCNB2 O95067 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNB3 Q8WWL7 1/20 0.32
▸ SLC40A1 Q9NP59 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ UCHL1 P09936 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22235380 1.00 TP53 (0.34) TP53DHODHPDE4APDE4BPDE4C
SCHEMBL22235382 1.00 TP53 (0.34) TP53DHODHPDE4APDE4BPDE4C
SCHEMBL29728922 1.00 TP53 (0.34) TP53DHODHPDE4APDE4BPDE4C
SCHEMBL22235354 0.92 KDM4E (0.38) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL22235909 0.90 SYK (0.31) PDE4DKDM4E
SCHEMBL22235890 0.90 SYK (0.31) PDE4DKDM4E
SCHEMBL22235484 0.75 ALDH1A1 (0.34) DHODHALDH1A1KDM4EGAAPOLB
SCHEMBL22235323 0.75 ALDH1A1 (0.34) DHODHALDH1A1KDM4EGAAPOLB
SCHEMBL22235440 0.75 ALDH1A1 (0.34) DHODHALDH1A1KDM4EGAAPOLB
SCHEMBL29728936 0.75 ALDH1A1 (0.34) DHODHALDH1A1KDM4EGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220125771-A1 SUBSTITUTED POLYCYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-04-28 — — US disclosed
CN-113825756-A Substituted polycyclic carboxylic acids, analogs thereof, and methods of use thereof 爱彼特生物制药公司 2021-12-21 — — CN disclosed
EP-3911653-A1 SUBSTITUTED POLYCYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2021-11-24 — — EP disclosed
WO-2020150366-A1 SUBSTITUTED POLYCYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2020-07-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220125771-A1 SUBSTITUTED POLYCYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME SLC10A1, NR1H4, HDGF TP53 205/4885DHODH 55/4885PDE4A 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback